Product information

Current status:

Cancelled Post Market

Current status date:

2003-11-18

Original market date: ^{See footnote 1}

1997-04-14

Product name:

NAROPIN INJ 7.5MG/ML

DIN:

02229416 Electronic product monograph is not available

Company:

ASTRAZENECA CANADA INC
1004 Middlegate Road, Suite 5000
Mississauga
Ontario
Canada L4Y 1M4

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Parenteral (Unspecified)

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

72:00.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N01BB09 ROPIVACAINE

Active ingredient group (AIG) number:^{See footnote5}

0133273004